DePuy Spine Launches Two New Products

SAN FRANCISCO – November 11, 2009 – DePuy Spine, Inc., expanded its portfolio for degenerative disease with the launch of two of its latest innovations, the UNIPLATE ® 2 Anterior Cervical Plate System, a next generation singlescrew midline fixation system, and the VERTIGRAFT ® VG2 ® Cervical Allograft with PRESERVON ® Technology, the first allograft that can be stored at room temperature in a fully hydrated state.

The company launched the products at the 24 th Annual Meeting of the North American Spine Society (NASS). In the last three years, DePuy Spine introduced 30 new products, including eight this year, encompassing traditional and minimally invasive solutions across degenerative disease, deformity, aging and complex spinal disorders.

“DePuy Spine is committed to continued innovation and filling patient and clinical needs across the entire spectrum of spinal disorders,” said Gary Fischetti, Worldwide President, DePuy Spine. “This commitment means offering solutions, not just products, to address the increasing needs of our customers and the increasing demand for spinal care being fueled by an aging and more active population.”

At NASS, DePuy Spine introduced the UNIPLATE 2 for oneor twolevel anterior cervical discectomy and fusion (ACDF). Singlescrew midline fixation, pioneered with the original UNIPLATE launched in 2005, allows the surgeon to affix an implant using one screw per vertebral body. This minimizes the need for retraction of soft tissue, such as the trachea and esophagus, during implantation.

The UNIPLATE 2 features a thinner profile between screw holes, providing flexible “bend zones” that allow surgeons to customize the plate to fit a patient’s anatomy, and has less material on both ends to reduce the risk of adjacent level impingement. It also has posterior cleats to reduce slippage and fourthgeneration CAMLOC ™ technology that offers visual, tactile and audible assurance that the screws are locked in place. Streamlined instrumentation enables surgeons to choose the method of implantation most appropriate to the patient’s needs.


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button